AVS 55th International Symposium & Exhibition
    BioMEMS Topical Conference Tuesday Sessions
       Session BM+BI+BO+NC-TuA

Invited Paper BM+BI+BO+NC-TuA8
Analysis and Diagnostics based on Nanomechanics

Tuesday, October 21, 2008, 4:00 pm, Room 309

Session: Microfluidics/Lab-on-a-Chip
Presenter: C. Gerber, University of Basel, Switzerland
Correspondent: Click to Email

In recent years we have taken AFM technology well beyond imaging, exploring new frontiers in bio analyses and diagnostics. Micro-fabricated silicon cantilevers arrays offer a novel label-free approach where ligand-receptor binding interactions occurring on the sensor generate nanomechanical signals - like bending or a change in mass - that is optically detected in-situ. We report the detection of multiple unlabelled biomolecules simultaneously down to picomolar concentrations within minutes. Differential measurements including reference cantilevers on an array of eight sensors enables sequence-specific detection of unlabelled DNA and is suitable to detect specific gene fragments within a complete genome (gene fishing). Expression of detection of inducible genes and the detection of total RNA fragments in an unspecific background will be shown. Ligand-receptor binding interactions, such as antigen recognition will be presented. Antibody activated cantilevers with sFv (single chain fragments) which bind to the indicator proteins show a significantly improved sensitivity which is comparable with the SPR (Surface Plasmon Resonance) technique. In addition, this technology offers a brought variety of receptor molecule applications such as e.g. membrane protein recognition, micro-organism detection, and enantiomeric separation. New coating procedures, enlargement of the active surface area by dendritic molecules as well as improvement of the receptor-cantilever chemical bond will be presented. These new findings may lead to a novel individual diagnostic assay in a combined label-free GENOMICs and PROTEOMIC biomarker sensor (COMBIOSENS). We foresee this novel technology being used as a tool to be applied in the upcoming field of systems biology and preventive medicine to evaluate treatment response efficacy for personalized medical diagnostics.